Metronomic treatment of advanced non-small-cell lung cancer with daily oral vinorelbine - a Phase I trial.
- DOI
- 10.2147/ott.s122106
- Published
- 2017
- Container
- OncoTargets and therapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.2147/ott.s122106,
title = {Metronomic treatment of advanced non-small-cell lung cancer with daily oral vinorelbine - a Phase I trial.},
author = {Guetz S and Tufman A and von Pawel J and Rittmeyer A and Borgmeier A and Ferré P and Edlich B and Huber RM},
year = {2017},
journal = {OncoTargets and therapy},
doi = {10.2147/ott.s122106},
url = {https://doi.org/10.2147/ott.s122106}
}RIS
TY - JOUR TI - Metronomic treatment of advanced non-small-cell lung cancer with daily oral vinorelbine - a Phase I trial. AU - Guetz S AU - Tufman A AU - von Pawel J AU - Rittmeyer A AU - Borgmeier A AU - Ferré P AU - Edlich B AU - Huber RM PY - 2017 JO - OncoTargets and therapy DO - 10.2147/ott.s122106 UR - https://doi.org/10.2147/ott.s122106 ER -
APA
S, G., A, T., J, V. P., A, R., A, B., P, F., B, E., & RM, H. (2017). Metronomic treatment of advanced non-small-cell lung cancer with daily oral vinorelbine - a Phase I trial.. OncoTargets and therapy. https://doi.org/10.2147/ott.s122106
Source records
- pubmed · retrieved 2026-09-27T08:29:20.886Z